New ‘Fastball’ test could help prevent Alzheimer’s curveballs
By
Aaron Dorman
Jul 13, 2023
An innovative ‘fastball’ technique for identifying Alzheimer’s years before a diagnosis received a major funding boost.
Letters promote congressional support for $353 million increase in federal funding for dementia initiatives
By
Kimberly Bonvissuto
May 13, 2024
Congressional support is growing for increased federal funding for dementia research, as evidenced by two recent letters to House appropriations subcommittee leadership.
PTSD, TBI interact with APOE ε4 to raise Alzheimer, dementia risk
Jan 06, 2023
Significant additive APOE ε4 interactions were seen with PTSD and TBI in veterans of European ancestry.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
More news for Friday, Oct. 27
By
Kimberly Bonvissuto
Oct 27, 2023
Assisted living worker charged with murder after shoving resident … Personality changes prior to cognitive impairment aren’t predictive of dementia … CDC releases COVID-19, RSV vaccine information...
Alzheimer’s disease most prevalent in East, Southeast, first-ever county-level data show
By
Kimberly Bonvissuto
Jul 18, 2023
East and Southeast US states have the highest prevalence of Alzheimer’s dementia, according to the first county-level study of disease occurrence.
$81 million NIH grant will study dementia care through workforce in assisted living, other settings
By
Kimberly Bonvissuto
Oct 05, 2023
A five-year, $81 million federal grant will fund a study to better understand the workforce caring for assisted living residents and others who are living with dementia in hopes of helping with recruitment...
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
Visionary Alzheimer’s forecasting software gets FDA approval
By
Aaron Dorman
Jan 30, 2024
A newly regulated Alzheimer’s software tool offers clarity on whether the condition is likely to progress to dementia in someone with mild cognitive impairment.
Assisted living providers can take steps to address workforce shortages, quality, Alzheimer’s Association...
By
Lois A. Bowers
Apr 22, 2024
As federal lawmakers ponder ways to address workforce shortages and quality in senior living communities and other long-term care settings, the Alzheimer’s Association and its advocacy affiliate, the...